General Genomics Inc.

General Genomics Inc.

Understanding the complexity of your individual health.

Print
Security Type
SAFE
Min Investment
$100
Location
Midland, TX
Offering Date
December 10, 2020
Expected Close Date
April 30, 2021
Target Raise
$50.00K-$1.07M
Deal Notes

Price Per Share: $1.00

Company Description

Curo46 uses Artificial Intelligence and our algorithm to take a holistic approach to your health. We collect data from all areas: medical history, genetic markers, consumption habits, health trackers, and more.

Key Deal Facts

Diseases and treatments affect everyone differently.
Underlying relationships are too complex to be understood by today’s health and medical industries.
Curo46’s AI revolutionizes our understanding of an individual’s health risks.
Our interface gives people control over their health/medical history and who gets access to it.
Our applications are fully protected and supported with patents.
Proven technical and commercial expertise to successfully develop, and deploy our products.
Existing contracts with the government, military, education institutions, and countless companies.
Stonebridge Advisory Inc. rendered a current fair market value estimated at $320,000,000.

Use of Proceeds

$50,000

  • We will able to add 2 full-time staff members and the amount will be distributed to cover the company's implementation strategy based on the outlined breakdown below: Marketing & Customer Acquisition 35%;  will cover advertising & promotions, selling expenses (e.g. travel, commissions), events & conferences, marketing team salaries (digital marketing manager, sales team and employees benefit costs. Operations & Salaries 35%; will cover bank charges, office rent, electricity, travel allowance, finance, operations, legal charges, insurance professional fees, salaries. Information Technology 12.5%; Infrastructure, internet, wireless, telephony, software, salaries. Research & Development 10%; Additional IP development, patent filings, technology scaling. Wefunder fee 7.5%.

 

$1,070,000

  • We will able to add 7 full-time staff members and the amount will be distributed to cover the company's implementation strategy based on the outlined breakdown below: Marketing & Customer Acquisition 50%;  will cover advertising & promotions, selling expenses (e.g. travel, commissions), events & conferences, marketing team salaries (account manager, digital marketing manager, marketing assistants, retail sales agent, sales team and employees benefit costs. Operations & Salaries 20%; will cover bank charges, office rent, electricity, travel allowance, finance, operations, legal charges, insurance professional fees, salaries (CEO, CFO, CTO, bookkeeper, accountant, hr manager, employee benefit cost). Information Technology 12.5%; Infrastructure, internet, wireless, telephony, software, salaries. Research & Development 10%; Additional IP development, patent filings, technology scaling. Wefunder fee 7.5%

Management Team / Advisory Board Bios

AJ Rosenthal, President
AJ Rosenthal’s career has spanned data science and sales. After serving eight plus years as a US Navy nuclear engineer, AJ built a career in the energy industry. His deep expertise has helped General Genomics secure 3 patents and apply for 20+ more.

Warren Dennis Gieck, SVP, Engineering & Product Development
With deep experience in AI development and market launch, Warren has led AI-driven digital transformations at global leaders GE and Baker Hughes. Additionally, he's built critical robotics and industrial automation programs, including GE’s Adaptix.

Caleb Stuart, SVP, General Counsel, and Secretary
Caleb brings business law and contracts expertise to General Genomics. After serving four years in the US Marine Corps and earning a JD, Caleb built the Stuart Firm, a practice focused on commercial litigation in the energy and construction industry.

Deal Notes

Price Per Share: $1.00

Amount Raised : $0
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments